지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2002.1
- 수록면
- 409 - 415 (7page)
이용수
초록· 키워드
오류제보하기
Purposes: Although the standard management oflimited stage small cell lung cancer is concurrent platinum-based chemotherapy with thoracic radiotherapy(TRT), the optimal timing of the TRT remains controversial.
We investigated the feasibility of concurrentchemoradiation for the patients with limited stage smallcell lung cancer after 2 cycles of combination chemotherapywith Etoposide/Cisplatin (EP).
Materials and Methods: EP consisted of Etoposide 100mg/m2 on day 1 to 3 and Cisplatin 70 mg/m2 on day 1.
Six cycles were given to the responders every 4 weeks.
Total 55 Gy (1.8 Gy once-daily or 1.2 Gy twice-daily, 5days per week) of TRT were given to the patients whoshowed at least a partial response after 2 cycles of EP.
The other patients were treated by the physician'sdecision. The patients with complete remission wererecommended to receive prophylactic cranial irradiation.
Results: Fifty patients were enrolled. Thirty-five (70%)of them showed responses (2 complete remissions and33 partial remissions) after 2 cycles of EP. Thirty-threeof the responders were given TRT starting with the 3rdcycle of EP. The nonresponders were treated with salvagechemotherapy and TRT. After completion of treatment for50 patients, the overall response rate was 86% (29complete remissions, 14 partial remissions). One patient(2%) showed stable disease, and 6 (12%) showed aprogressive disease. The median progression free survivalwas 326 days and the median survival time was 410days. One-, 2-, 3-, 4- and 5-year survival rates were 62%,24%, 14%, 9% and 6%, respectively. As hematologic toxicitiesduring chemoradiation, 35.1% with grade III/IV neutropeniaand 18.9% with grade III/IV thrombocytopeniawere noted. Grade II/III radiation pneumonitis and radiationesophagitis were noted in 5/1 and 13/1 patients (15.2%/3.0% and 39.4%/3.0%), respectively. One patient died ofsepticemia during chemoradiation.
Conclusion: The concurrent EP and TRT after 2 cyclesof EP was feasible in limited stage small cell lung cancer.
Further study is required for the indentification of optimumtiming of TRT during combination chemotherapy.
(Cancer Research and Treatment 2002;34:409-415)
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
수술이 불가능한 제 III기 비소세포폐암에서 Cisplatin 및 Etoposide(EP)의 화학요법과 방사선요법의 병행요법(2상 임상연구)
Tuberculosis and Respiratory Diseases
1997 .01
-
Timing of Thoracic Radiotherapy in Limited Stage Small Cell Lung Cancer: Results of Early Versus Late Irradiation from a Single Institution in Turkey
Asian Pacific journal of cancer prevention : APJCP
2014 .01
-
제한병기 소세포폐암에서 흉부 방사선 치료의 도입 시기에 따른 치료 효과의 비교 분석
Tuberculosis and Respiratory Diseases
1996 .01
-
소세포폐암에 대한 Cisplatin과 Etoposide(PVP) 복합화학요법의 효과
Tuberculosis and Respiratory Diseases
1994 .01
-
Etoposide-Cisplatin Alternating with Vinorelbine-Cisplatin Versus Etoposide-Cisplatin Alone in Patients with Extensive Disease Combined with Small Cell Lung Cancer
Asian Pacific journal of cancer prevention : APJCP
2014 .01
-
Once vs. Twice Daily Thoracic Irradiation in Limited Stage Small Cell Lung Cancer
Radiation oncology journal : ROJ
1998 .01
-
Randomized Phase III Trial of Irinotecan Plus Cisplatin versus Etoposide Plus Cisplatin in Chemotherapy-Naïve Korean Patients with Extensive-Disease Small Cell Lung Cancer
Cancer Research and Treatment
2019 .01
-
Oral Etoposide, Ifosfamide and Cisplatin in the Treatment of Extensive Disease Small Cell Lung Cancer
Cancer Research and Treatment
2002 .01
-
Optimal Timing of Radiotherapy with Alternating/Sequential Radio-Chemotherapy for Limited-stage Small Cell Lung Cancer
Asian Pacific journal of cancer prevention : APJCP
2014 .01
-
Effect of early chemoradiotherapy in patients with limited stage small cell lung cancer
Radiation oncology journal : ROJ
2013 .01
-
Treatment of Small Cell Lung Cancer
Cancer Research and Treatment
2003 .01
-
Phase II Study of Induction Irinotecan + Cisplatin Chemotherapy Followed by Concurrent Irinotecan + Cisplatin Plus Twice-Daily Thoracic Radiotherapy
Tuberculosis and Respiratory Diseases
2007 .01
-
Clinical Effects of The Combination Chemotherapy of Docetaxel and Cisplatin in Non-Small Cell Lung Cancer
대한약학회 학술대회
2001 .01
-
진행성 비소세포 폐암 환자에서 Ifosfamide, Cisplatin Etoposide(ICE) 복합화학요법의 효과
Tuberculosis and Respiratory Diseases
2002 .01
-
소세포폐암에서 Etoposide 투여 후 발생한 아나필락시스 1예
Tuberculosis and Respiratory Diseases
2009 .01
-
A Comparison of Platinum-Based Combination Chemotherapy in Patient with Non-Small Cell Lung Cancer
대한약학회 학술대회
2001 .01
-
국소 진행된 두경부암의 병합요법 : 치료 방법에 따른 비교
대한 두경부 종양 학술지
2001 .01
-
국한성 소세포 폐암에 대한 Etoposide (VP-16), Ifosfamide, Carboplatin 복합화학요법과 흉부 방사선의 동시 병합치료 효과
대한내과학회지
2006 .01
-
Comparison of Vinorelbine, Ifosfamide and Cisplatin (NIP) and Etoposide and Cisplatin (EP) for Treatment of Advanced Combined Small Cell Lung Cancer (cSCLC) Patients: A Retrospective Study
Asian Pacific journal of cancer prevention : APJCP
2012 .01
-
Effect of Combination Chemotherapy with Docetaxel Plus Cisplatin in Patients with Advanced Non-Small Cell LungCancer
Cancer Research and Treatment
2003 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0